Pharmaceutical Executive April 20, 2023
Lisa Henderson

Industry insights on how pharma is faring in tapping new innovations and approaches in digital health.

In two Pharma 2023 sessions, “Digital Health: Does Pharma Know its Role Yet?” and “Power Patient-Reported Outcomes through Digital Health Tools,” the reasons cited for pharma being involved in digital health were threefold: engage patients for the long-term journey with their conditions; keep health systems and physicians connected to their patients; and find patients who need higher efficacy treatments at the right time.

In the second session, Johannes Munding, director, patient experience design and solutions, neuroscience, Novartis, noted of digital health solutions that it’s a good idea to understand how a patient is doing in real-time, in the real-world, and shift away from current...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Digital Health, Pharma, Pharma / Biotech, Technology, Trends
NCPA Continues Push for Congressional PBM, Health Care Reform
Journalists Give Insights Into Opioid Settlements and Picking a Nursing Home
FTC sues PBMs and GPOs for insulin price collusion
FTC sues drug middlemen for allegedly inflating insulin prices
Pharma Pulse 9/20/24: The Benefit to Adapting Operating Models, 50% of US Women Skip or Delay Medical Care & more

Share This Article